(Q41694502)

7 October 2017

title

beta blockade with pindolol: differential cardiac and renal effects despite similar plasma kinetics in normal and uremic man (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A459247

3 July 2022

Beta blockade with pindolol: Differential cardiac and renal effects despite similar plasma kinetics in normal and uremic man (English)

1 reference

23 May 2023

1 reference

23 May 2023

author name string

R. L. Galeazzi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A459247

3 July 2022

M. Gugger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A459247

3 July 2022

P. Weidmann

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A459247

3 July 2022

language of work or name

English

0 references

publication date

1 June 1979

1 reference

full work available at URL

7 October 2017

https://api.elsevier.com/content/article/PII:S0085253815321001?httpAccept=text/xml

1 reference

https://api.elsevier.com/content/article/PII:S0085253815321001?httpAccept=text/plain

23 May 2023

1 reference

23 May 2023

1 reference

7 October 2017

volume

15

1 reference

7 October 2017

issue

6

1 reference

7 October 2017

page(s)

661-668

1 reference

Pharmacokinetics of pindolol in man.

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.86

7 January 2021

Pharmacokinetics of unlabelled and14C-labelled pindolol in uraemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.86

7 January 2021

Relationship between renal function and elimination kinetics of pindolol in man

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.86

7 January 2021

Pharmacokinetics and hepatic extraction ratio of pindolol in hypertensive patients with normal and impaired renal function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.86

7 January 2021

Radioimmunoassay for aldosterone without chromatography. 2. Determination of plasma aldosterone

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.86

7 January 2021

The renin system: Variations in man measured by radioimmunoassay or bioassay

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.86

7 January 2021

A method for the fluorimetric determination of 4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB46), a beta-blocking agent, in plasma and urine.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.86

7 January 2021

Plasma concentrations and the time-course of beta blockade due to propranolol

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.86

7 January 2021

Pharmacokinetics and effects of propranolol in terminal uraemic patients and in patients undergoing regular dialysis treatment

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.86

7 January 2021

The biotransformation of drugs in renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.86

7 January 2021

Prediction of drug dosage in patients with renal failure using data derived from normal subjects

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.86

7 January 2021

beta-Adrenoceptor antagonists and respiratory function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.86

7 January 2021

The control of renin release

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.86

7 January 2021

Is the adrenergic control of renin release dominant in man?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.86

7 January 2021

Comparison of the effects on renin release of beta adrenergic antagonists with differing properties

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.86

7 January 2021

Interrelations between blood pressure, blood volume, plasma renin and urinary catecholamines during beta-blockade in essential hypertension (author's transl)

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.86

7 January 2021

Plasma renin and blood pressure during treatment with methyldopa

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.86

7 January 2021

Cardiovascular and endocrine profile of adrenergic neurone blockade in normal and hypertensive man

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.86

7 January 2021

Dissociation between renin and arterial pressure responses to beta-adrenergic blockade in human essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.86

7 January 2021

Immediate plasma renin response to propranolol: differentiation between essential and renal hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.86

7 January 2021

Renin Release, Saralasin and the Vasodilator-Beta-Blocker Drug Interaction in Man

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.86

7 January 2021

Effect of beta-adrenergic blockade on plasma-renin activity and intractable hypertension in patients receiving regular dialysis treatment

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.86

7 January 2021

Propranolol Effects in Long-Term Hemodialysis Patients with Renin-Dependent Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.86

7 January 2021

Mild high-renin essential hypertension. Neurogenic human hypertension?

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.86

7 January 2021

The effect of chronic adrenergic receptor blockade on plasma renin activity in man

1 reference

https://api.crossref.org/works/10.1038%2FKI.1979.86

7 January 2021

Renin-Suppressive Potency of Various Beta-Adrenergic Blocking Agents at Supine Rest and during Upright Exercise

20

1 reference

23 May 2023

Identifiers

DOI

10.1038/KI.1979.86

1 reference

7 October 2017

1 reference